Home / business / Wockhardt Shares Climb 14% after Getting Approval for Two New Antibiotics

Wockhardt Shares Climb 14% after Getting Approval for Two New Antibiotics

-
In a filing to stock exchanges, Wockhardt said that it has received approval from the Drugs Controller General of India (DCGI) for its two new antibiotics -- Emrok (intravenous infusion) and EMROK O (Oral) – to treat skin and other drug-resistant infections.

from Top Business News- News18.com
Read The Rest:timesnownews...
Wockhardt Shares Climb 14% after Getting Approval for Two New Antibiotics Wockhardt Shares Climb 14% after Getting Approval for Two New Antibiotics Reviewed by Team Exprssnews on January 16, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.